Partial lipodystrophy is a rare condition where the body loses fat from specific parts of the body while sometimes accumulating excess fat in other areas, leading to a distinctive appearance and potentially serious metabolic complications that can affect overall health and wellbeing.

Understanding Partial Lipodystrophy

Partial lipodystrophy refers to a group of rare disorders characterized by selective loss of adipose tissue, which is the fat tissue normally found beneath the skin and around internal organs. Unlike generalized forms where fat loss affects the entire body, partial lipodystrophy causes fat to disappear from specific regions while potentially building up in others. This abnormal distribution creates a distinctive physical appearance and triggers metabolic problems because fat tissue plays essential roles beyond just storing energy. It releases hormones like leptin, which helps regulate appetite and metabolism, cushions organs, keeps the body warm, and moderates inflammation throughout the body.^[1]

The condition can be inherited from parents, known as familial partial lipodystrophy, or it can develop during a person’s lifetime, called acquired partial lipodystrophy. Both types share the common feature of selective fat loss, but they differ in their causes, patterns of fat distribution, and the age at which symptoms first appear. The loss of functional fat tissue creates what specialists describe as a lipid-partitioning disorder, where the body cannot properly store fat in the right places, leading to fat accumulating where it shouldn’t, such as in the liver, muscles, and bloodstream.^[3]

How Common Is Partial Lipodystrophy

Partial lipodystrophy is extremely rare, affecting very few people worldwide. The overall prevalence of familial partial lipodystrophy is estimated at less than 1 in 1 million people in Europe, though experts believe this figure likely underestimates the true number of cases because many people with milder forms may never receive a diagnosis.^[5] One estimate suggests familial partial lipodystrophy affects approximately 1 in 1 million people overall, with more than 500 cases of type 2 (the most common form) reported in medical literature.^[1]

Acquired partial lipodystrophy, also known as Barraquer-Simons syndrome, is even more uncommon. Since the condition was first characterized in the early 20th century, approximately 250 cases have been documented in English medical literature. This form typically begins in childhood, with most cases appearing around age 7 to 8 years. It predominantly affects females, with women diagnosed far more often than men.^[4]

One interesting pattern observed with familial partial lipodystrophy is that women tend to be diagnosed more frequently than men. This doesn’t necessarily mean women are more likely to have the condition genetically, but rather that the loss of fat from the hips and limbs is more easily recognized in women’s bodies, and metabolic complications like diabetes and high triglycerides occur more commonly in affected women than men.^[1]

What Causes Partial Lipodystrophy

The causes of partial lipodystrophy differ significantly depending on whether the condition is familial (inherited) or acquired. For familial partial lipodystrophy, the root cause lies in changes to specific genes that provide instructions for making proteins involved in fat storage and the development of fat cells called adipocytes. When these genes contain mutations, they reduce or eliminate the function of their respective proteins, which impairs how fat cells develop, maintain their structure, or function properly. This makes the body unable to store and use fat normally.^[1]

The most common form, familial partial lipodystrophy type 2, results from mutations in the LMNA gene, which encodes proteins called A-type lamins that are part of the structural framework of cell nuclei. Other less common genetic forms are caused by mutations in different genes: PPARG causes type 3, PLIN1 causes type 4, CIDEC causes type 5, and LIPE causes type 6. Some forms appear to have multiple genetic causes that haven’t yet been fully identified. Many patients who clearly have the physical and metabolic features of familial partial lipodystrophy do not have mutations in any of the known genes, suggesting other disease-causing genes remain to be discovered.^[5][7]

The precise cause of fat loss in acquired partial lipodystrophy remains unclear. However, activation of an alternate pathway in the immune system called the complement pathway appears to play a role. Most patients with this form show evidence of problems with complement system components, particularly low levels of a protein called C3 and the presence of an autoantibody called C3 nephritic factor. The condition often develops following an acute febrile viral illness, most commonly measles. The fat loss typically begins on the face and progressively moves downward to affect the neck, arms, and trunk.^[4][16]

Who Is at Risk for Partial Lipodystrophy

For familial partial lipodystrophy, the primary risk factor is having a parent who carries a mutation in one of the genes associated with the condition. Most forms of familial partial lipodystrophy are inherited in an autosomal dominant pattern, meaning only one copy of the altered gene from one parent is sufficient to cause the disorder. In rarer cases, the inheritance follows an autosomal recessive pattern, requiring a copy of the mutated gene from both parents. It’s also possible for someone to carry a disease-causing gene mutation without developing symptoms, which can make predicting who will be affected more complex.^[5][8]

Family history is a strong indicator of risk. When one person is diagnosed with familial partial lipodystrophy, their close relatives, particularly siblings and children, may also be at risk and should be evaluated. Women in families with familial partial lipodystrophy face higher risks of developing noticeable symptoms and metabolic complications, making screening especially important for female family members.^[9]

For acquired partial lipodystrophy, several factors appear to increase risk. The condition predominantly affects females, with women accounting for roughly four times as many cases as men. It typically begins during childhood or adolescence, though rarely it can develop after age 30. A history of recent viral infection, particularly measles, often precedes the onset of fat loss. People with autoimmune diseases face increased risk; systemic lupus erythematosus is the most common autoimmune condition associated with acquired partial lipodystrophy, but others include dermatomyositis, pernicious anemia, celiac disease, and rheumatoid arthritis.^[4][16]

Recognizing the Symptoms of Partial Lipodystrophy

The symptoms of partial lipodystrophy vary depending on which type a person has, but the hallmark feature is the selective loss of fat from certain body regions. In familial partial lipodystrophy, patients typically appear completely normal at birth and throughout early childhood. The changes in fat distribution usually become noticeable around puberty, when adolescents begin losing fat from their arms, legs, buttocks, and trunk. This loss gives these body parts a very muscular appearance because muscles become more visible without the cushioning layer of subcutaneous fat. Meanwhile, fat accumulates excessively in other areas, particularly the face, neck, chin, and sometimes between the shoulder blades or in the abdominal cavity. This pattern of fat distribution is sometimes described as “cushingoid” because it resembles features seen in Cushing disease, though the two conditions are completely different.^[1][5]

Many people with familial partial lipodystrophy develop darkened, thickened, velvety skin in body folds and creases, particularly at the neck, armpits, and groin. This condition, called acanthosis nigricans, occurs because of high insulin levels in the bloodstream and serves as a visible sign of underlying insulin resistance. Women with the condition commonly experience hormonal imbalances that cause irregular menstrual periods, increased facial and body hair (hirsutism), multiple cysts on the ovaries, and difficulty becoming pregnant. Some affected individuals, particularly those with type 2, may develop muscle weakness, abnormalities of the heart muscle, and problems with the heart’s electrical conduction system.^[1][5]

In acquired partial lipodystrophy, fat loss typically begins on the face and gradually progresses downward to affect the neck, shoulders, arms, and chest during childhood. The progression can be variable, sometimes affecting only the face in milder cases. Some individuals may simultaneously develop excess fat around the abdomen, legs, or buttocks, creating a striking contrast. Unlike familial forms, diabetes and impaired glucose tolerance are relatively uncommon in acquired partial lipodystrophy, appearing in only about 6.7% and 8.9% of patients respectively. This difference likely relates to the more limited extent of fat loss compared to other forms of lipodystrophy.^[4][16]

Beyond the visible changes in appearance, many individuals experience persistent fatigue that can significantly impact daily activities. Some describe needing frequent rest periods or feeling exhausted even after adequate sleep. Young children with familial partial lipodystrophy may experience painful muscle cramps, particularly in the calf muscles. The metabolic disturbances can cause excessive hunger, especially in forms where leptin levels are very low, as leptin normally signals the brain that the body has sufficient energy stores.^[20]

Preventing Partial Lipodystrophy and Its Complications

For inherited forms of partial lipodystrophy, there is currently no way to prevent the condition itself from developing, as it results from genetic mutations present from birth. However, families with a known history of familial partial lipodystrophy can benefit from genetic counseling before having children. Genetic counselors can explain inheritance patterns, discuss the likelihood of passing the condition to offspring, and describe available genetic testing options. When one family member is diagnosed, testing other relatives can identify those at risk before symptoms develop, allowing for earlier monitoring and intervention.^[5]

For acquired forms, since the precise mechanisms remain poorly understood and the condition sometimes follows viral infections, there are no proven strategies to prevent its onset. Maintaining up-to-date vaccinations against preventable infectious diseases represents a reasonable general health measure, though a direct link to preventing acquired partial lipodystrophy has not been established.

What can be addressed, however, are the metabolic complications that develop because of the fat loss. Even though the underlying lipodystrophy cannot be prevented, people diagnosed with the condition can take important steps to minimize complications. Adopting a healthy diet low in fat, particularly limiting total fat intake to 30% or less of daily calories, helps reduce triglyceride levels. The fats consumed should primarily be cis-monounsaturated and long-chain omega-3 fatty acids rather than saturated fats. When triglyceride levels become severely elevated (above 2000 mg/dL), very low-fat diets containing less than 15-20% fat may be necessary to prevent pancreatitis, though this can be challenging to maintain.^[15]

Regular physical activity provides multiple benefits for people with partial lipodystrophy. Exercise improves insulin sensitivity, helps control blood sugar levels, supports cardiovascular health, and can improve overall energy levels. Combined with dietary modifications, physical activity forms the foundation of managing metabolic complications. Avoiding excessive alcohol consumption protects the liver, which is already vulnerable to fat accumulation in lipodystrophy. Maintaining a healthy weight within normal body mass index ranges, when possible given the abnormal fat distribution, helps reduce strain on the cardiovascular system.^[11]

Regular medical screening plays a crucial role in catching complications early when they are most treatable. People with partial lipodystrophy should have their blood sugar (glucose) levels, insulin levels, triglycerides, cholesterol levels, and liver function tests checked regularly. Blood pressure should be monitored frequently, as hypertension commonly develops. Women should be screened for polycystic ovary syndrome and hormonal imbalances. Imaging studies may be recommended to evaluate the liver for fat accumulation and to monitor heart function. These proactive screening measures allow healthcare providers to detect problems before they cause irreversible damage and to adjust treatments promptly.^[5]

How Partial Lipodystrophy Affects the Body

To understand the pathophysiology of partial lipodystrophy, it helps to recognize that adipose tissue is not simply an inert storage depot. Fat tissue functions as an active endocrine organ that releases numerous hormones and signaling molecules called adipokines. Among the most important is leptin, which regulates appetite, metabolism, and how the body processes glucose and lipids. When the body loses significant amounts of functional adipose tissue, leptin production decreases dramatically. Without adequate leptin, the brain doesn’t receive proper signals about energy stores, leading to excessive hunger in some forms. More critically, tissues throughout the body lose sensitivity to insulin, and glucose and fat metabolism become severely disrupted.^[3]

The reduced ability to store energy in subcutaneous fat forces the body to deposit fat in inappropriate locations, a process called ectopic fat accumulation. Excess fat builds up in the liver, causing hepatic steatosis (fatty liver), which can progress to inflammation (steatohepatitis) and eventually cirrhosis. Fat accumulates in skeletal muscles, interfering with their ability to respond to insulin and contributing to insulin resistance. Fat deposits around and within the pancreas may impair its ability to produce insulin. This ectopic fat in organs and tissues where it doesn’t belong causes inflammation and cellular dysfunction that drives many of the metabolic complications.^[3][11]

Insulin resistance develops early and progressively worsens in most forms of partial lipodystrophy. The body’s cells cannot adequately respond to insulin, even when large amounts are present. To compensate, the pancreas produces ever-increasing quantities of insulin, leading to very high insulin levels in the bloodstream (hyperinsulinemia). This state of insulin resistance eventually overwhelms the pancreas’s capacity, and blood sugar levels rise, leading first to prediabetes and then to frank diabetes mellitus. The diabetes seen in lipodystrophy, sometimes called lipoatrophic diabetes, tends to be extremely difficult to control, often requiring very high doses of insulin and multiple medications.^[1]

Lipid metabolism becomes profoundly abnormal in partial lipodystrophy. Without adequate fat storage capacity in subcutaneous adipose tissue, triglycerides accumulate in the bloodstream, causing hypertriglyceridemia. These elevated triglyceride levels create a milky appearance in blood samples and dramatically increase the risk of acute pancreatitis, a painful and potentially life-threatening inflammation of the pancreas. Levels of HDL cholesterol (the “good” cholesterol) typically decrease, while other harmful lipid particles may increase, creating a lipid profile that promotes atherosclerosis and cardiovascular disease. The liver’s attempt to process excess fats contributes to hepatic steatosis and abnormal liver function.^[5]

In women, hormonal imbalances frequently develop as a consequence of insulin resistance and metabolic dysfunction. High insulin levels interfere with normal ovarian function and hormone production, leading to elevated male hormones (androgens). This causes hirsutism (excessive hair growth in male-pattern areas), irregular or absent menstrual periods, the development of multiple ovarian cysts characteristic of polycystic ovary syndrome, and reduced fertility. The hormonal disruptions can also contribute to acne and male-pattern baldness in some women.^[1][5]

For acquired partial lipodystrophy specifically, kidney complications represent an additional serious concern. About 20% of people with this form develop membranoproliferative glomerulonephritis, a type of kidney inflammation caused by immune system dysfunction. The kidney damage results from deposits of immune complexes in the kidney’s filtering units. Proteinuria (protein in the urine) occurs in about 45% of cases. People with acquired partial lipodystrophy who have low C3 complement levels and the presence of C3 nephritic factor face the highest risk for these kidney complications, which can progress to kidney failure if not monitored and treated appropriately.^[4][16]